A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Chen, Christine
Paul, Harminder [1 ]
Xu, Wei
Kukreti, Vishal [1 ]
Trudel, Suzanne [1 ]
Wei, Ellen [1 ]
Li, Zhi Hua [1 ]
Brandwein, Joseph [1 ]
Pantoja, Mariela [1 ]
Leung-Hagensteijn, Chungyee [1 ]
机构：
[1] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [2] An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle L.
    Trudel, Suzanne
    BLOOD, 2015, 126 (23)
  • [3] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Kakar, Sumeet
    Le, Lisa W.
    Wei, Ellen N.
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle
    Spaner, David
    Croucher, Danielle
    Sherry, Barbara
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
  • [4] An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Del Rizzo, Luisa
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Brown, Michelle
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [5] Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Wang, Trina
    Le, Lisa W.
    Kukreti, Vishal
    Wei, Ellen Nong
    Lau, Anthea
    Bergsagel, P. Leif
    Dave, Nimisha
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [6] Fludarabine, Rituximab, and Lenalidomide in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): A Phase I/II Trial of the Sarah Cannon Research Institute
    Flinn, Ian W.
    Cooper, R. Seth
    Thompson, Dana S.
    Waselenko, Jamie K.
    Reeves, James, Jr.
    Wise, Rudolph L.
    Hainsworth, John D.
    Berdeja, Jesus G.
    BLOOD, 2012, 120 (21)
  • [7] Phase II multicenter trial of pentostatin and rituximab in patients with previously treated and untreated chronic lymphocytic leukemia (CLL).
    Yunus, F
    George, S
    Smith, J
    Geils, G
    Geils, G
    BLOOD, 2003, 102 (11) : 360B - 361B
  • [8] Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)
    Blum, Kristie A.
    Jones, Jeffrey A.
    Andritsos, Leslie
    Flynn, Joseph M.
    Deam, Deidre
    Heerema, Nyla A.
    Phelps, Mitchell
    Johnson, Amy J.
    Grever, Michael R.
    Byrd, John C.
    BLOOD, 2010, 116 (21) : 1027 - 1027
  • [9] Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
    Soumerai, Jacob D.
    Davids, Matthew S.
    Werner, Lillian
    Fisher, David C.
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2931 - 2938
  • [10] Results of a phase II multicenter study of obinutuzumab plus bendamustine in pts with previously untreated chronic lymphocytic leukemia (CLL).
    Sharman, Jeff Porter
    Yimer, Habte Aragaw
    Boxer, Michael
    DiBella, Nicholas
    Babu, Sunil
    Li, Jia
    Mun, . . . Yong Jun
    Skettino, Sandra L.
    Danilov, Alexey Valeryevich
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345